Dow Up0.35% Nasdaq Down0.02%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.39 Aug 20, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 1,154   1,202   5,498   1,362  
Cost of Revenue90  103  1,266  111  
Gross Profit 1,064   1,099   4,231   1,251  
Operating Expenses
Research Development8,142  7,566  7,514  7,048  
Selling General and Administrative2,444  2,467  1,951  1,880  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (9,522) (8,933) (5,233) (7,677)
Income from Continuing Operations
Total Other Income/Expenses Net(11)31  12  (9)
Earnings Before Interest And Taxes(9,533)(8,902)(5,222)(7,686)
Interest Expense -   -   -   -  
Income Before Tax(9,533)(8,902)(5,222)(7,686)
Income Tax Expense1  (5)5  25  
Minority Interest28  25  25  28  
Net Income From Continuing Ops(9,506)(8,872)(5,201)(7,683)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (9,506) (8,872) (5,201) (7,683)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (9,506) (8,872) (5,201) (7,683)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.